[1]
Sun, H.; Ringdahl, U.; Homeister, J.W.; Fay, W.P.; Engleberg, N.C.; Yang, A.Y.; Rozek, L.S.; Wang, X.; Sjöbring, U.; Ginsburg, D. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science, 2004, 305, 1283-1286.
[2]
Sun, H.; Xu, Y.; Sitkiewicz, I.; Ma, Y.; Wang, X.; Yestrepsky, B.D.; Huang, Y.; Lapadatescu, M.C.; Larsen, M.J.; Larsen, S.D.; Musser, J.M.; Ginsburg, D. Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice. Proc. Natl. Acad. Sci. USA, 2012, 109, 3469-3474.
[3]
Wang, N.; Qi, F.; He, X.; Shi, H.; Anderson, D.W.; Li, H.; Sun, H. Preparation and pharmacokinetic characterization of an anti-virulence compound nanosuspensions. Pharmaceutics, 2021, 13(10), 1586.
[4]
Pulakat, L.; Chen, H.H.; Gavini, M.P.; Ling, L.A.; Tang, Y.; Mehm, A.; Martin, G.L.; Beale, C.N.; Mooney, B.P.; Sun, H. Transdermal delivery of high molecular weight antibiotics to deep tissue infections via Droplette Micromist Technology Device (DMTD). Pharmaceutics, 2022, 14(5)
[PMCID: PMC9146216]
[PMCID: PMC9146216]
[5]
Hong, Q.; Sun, H.; Chen, M.; Zhang, S.; Yu, Q. Plasma treatment effects on destruction and recovery of Porphyromonas gingivalis biofilms. PLoS One, 2022, 17(9), e0274523.
[PMCID: PMC9473617]
[PMCID: PMC9473617]
